Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression
- PMID: 22123272
- PMCID: PMC3233981
- DOI: 10.1097/JGP.0b013e3182051a9b
Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression
Abstract
Objectives: Depression in older adults is often undertreated due, in part, to medication costs. We examined the impact of improved prescription drug coverage under Medicare Part D on use of antidepressants, medication choice, and adherence.
Design, setting and participants: Observational claims-based study of older adults with depression (ICD-9: 296.2, 296.3, 311, 300.4) continuously enrolled in a Medicare managed care plan between 2004 and 2007. Three groups with limited ($150 or $350 quarterly caps) or no drug coverage in 2004-2005 obtained Part D benefits in 2006. A comparison group had stable employer-sponsored coverage throughout.
Measurements: Any antidepressant prescription fill, antidepressant choice (tricyclics or monoamine oxidase inhibitors versus newer antidepressants), and adherence (80% of days covered) in the first 6 months of treatment.
Results: : Part D was associated with increased odds of any antidepressant use among those who previously lacked coverage (odds ratio [OR] 1.61, 95% confidence interval [CI] 1.41-1.85) but odds of use did not change among those with limited prior coverage. Use of older antidepressant agents did not change with Part D. All three groups whose coverage improved with Part D had significantly higher odds of 80% of days covered with an antidepressant (OR = 1.86 [95% CI: 1.44-2.39] for no coverage, 1.74 [95% CI: 1.25%3.42] for $150 cap; and 1.19 [95% CI: 1.06-1.34] for the $350 cap groups).
Conclusions: Medicare Part D was associated with improvements in antidepressant use and adherence in depressed older adults who previously had no or limited drug coverage but not with changes in use of older agents. use and adherence in depressed older adults who previously had no or limited drug coverage but not with changes in use of older agents.
Figures
References
-
- Charney DS, Reynolds CF, Lewis L, et al. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psych. 2003;60 - PubMed
-
- Bruce ML, Ten Have TR, Reynolds CF, 3rd, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. JAMA. 2004;291:1081–1091. - PubMed
-
- Waern M, Rubenowitz E, Wilhelmson K. Predictors of suicide in the old elderly. Gerontology. 2003;49:328–334. - PubMed
-
- Katon W. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry. 2003;54:216–226. - PubMed
-
- Unutzer J, Patrick DL, Simon GE, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4 year prospective study. JAMA. 1997;277:1618–1623. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG034056/AG/NIA NIH HHS/United States
- R01 AG027017/AG/NIA NIH HHS/United States
- R01HS017695/HS/AHRQ HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- P30 MH071944/MH/NIMH NIH HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- KL2 RR-024154-04/RR/NCRR NIH HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- R01AG027017/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- KL2 RR024154/RR/NCRR NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- P30MH71944/MH/NIMH NIH HHS/United States
- T32AG021885/AG/NIA NIH HHS/United States
- KL2 TR000146/TR/NCATS NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
